KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int Suppl 2018; 8:91–165.
Park H, et al. Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD. Hepatology 2018; 67:492–504.
Jadoul M, et al. Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients. Kidney Int 2019; 95:939–947.
Pol S, et al. Hepatitis C virus and the kidney. Nat Rev Nephrol 2019; 15:73–86.
De Vita S, et al. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum 2012; 64:843–853.
Towards elimination of viral hepatitis by 2030. Lancet 2016; 388:308.
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory